個人積分：8703分
文章編號：77321234
Trading in the shares of the company was halted after they fell 6%.
The Chinese trial showed the antiviral remdesivir did not improve patients' condition or reduce the pathogen's presence in the bloodstream, the report said.
Researchers studied 237 patients, giving the drug to 158 and comparing their progress with the remaining 79. The drug also showed significant side effects in some, which meant 18 patients were taken off it, according to the Financial Times.
在中國進行的第一階段實驗,完全失敗.
因此中國政府終止進入第二階段.
在237個樣本內,對158位投藥,79位為對照組.
藥物不但無效,而且對部分病患產生嚴重副作用,以致於18位病患退出實驗.
